According to one study, PFKP plays a critical role in β-catenin transactivation mediated by epidermal growth factor receptor (EGFR) activation, which may enhance brain tumor development and GBM cell proliferation, invasion, and migration, highlighting the possibility of targeting PFKP Y64 phosphorylation to treat GBM [28]. This evidence concerns the gene PFKP and brain neoplasm.